Analyzing Firefly Neuroscience (NASDAQ:AIFF) and Nutanix (NASDAQ:NTNX)

Firefly Neuroscience (NASDAQ:AIFF) and Nutanix (NASDAQ:NTNX) are both business services companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, analyst recommendations, profitability, risk and dividends.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Firefly Neuroscience and Nutanix, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Firefly Neuroscience	0	0	0	0	0.00
Nutanix	0	3	12	0	2.80

Nutanix has a consensus target price of $79.50, indicating a potential upside of 13.12%. Given Nutanix’s stronger consensus rating and higher probable upside, analysts clearly believe Nutanix is more favorable than Firefly Neuroscience.

Risk and Volatility

Firefly Neuroscience has a beta of 3.06, suggesting that its stock price is 206% more volatile than the S&P 500. Comparatively, Nutanix has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500.

Valuation & Earnings

This table compares Firefly Neuroscience and Nutanix”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Firefly Neuroscience	$7.98 million	12.92	-$2.03 million	N/A	N/A
Nutanix	$2.15 billion	8.76	-$124.78 million	($0.35)	-200.80

Firefly Neuroscience has higher earnings, but lower revenue than Nutanix.

Insider & Institutional Ownership

5.0% of Firefly Neuroscience shares are held by institutional investors. Comparatively, 85.3% of Nutanix shares are held by institutional investors. 8.4% of Firefly Neuroscience shares are held by insiders. Comparatively, 6.8% of Nutanix shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Firefly Neuroscience and Nutanix’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Firefly Neuroscience	-73.72%	-276.50%	-133.02%
Nutanix	-3.54%	-12.28%	3.30%

Summary

Nutanix beats Firefly Neuroscience on 8 of the 12 factors compared between the two stocks.

About Firefly Neuroscience

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.

About Nutanix

Nutanix, Inc. engages in the provision of a cloud platform leveraging web-scale engineering and consumer-grade design. It operates through the following geographic segments: United States, Europe, the Middle East, Africa, Asia Pacific, and Other Americas. The firm also provides software solutions and cloud services to customers’ enterprise infrastructure. The company was founded by Dheeraj Pandey, Ajeet Singh, and Mohit Aron in 2009 and is headquartered in San Jose, CA.